维普中文期刊产品整合服务
141篇 您的检索式:作者名="P Musto"
    题名 作者 年代 出处 被引量
1Bortezomib for progressive myeloma after autologous stem cell transplantation and thalidomide显示文摘MUSTO P FALCOME A SANPAOLO G 2006Leuk Res2006,30,3:1
2Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features 显示文摘D' Arena G Musto P Cascavilla N 1998Haematologica1998,83,3:1
3Effect of morphology on the relaxation processes and mechanical properties in polyimide/silica hybrids显示文摘Ragosta G Musto P Abbate M 2007Macromol Symp2007,247,:1
4Efficacy and safety of bortezomib in patients with plasma cell leukemia 显示文摘Musto P Rossini F Gay F 2007Cancer2007,109,11:1
5Malcated Polyisbutylene:a Novel Toughener for Unsaturated Polyester Resins显示文摘Abbate M Martuscelli E Musto P 1995Polymer Science1995,58,10:1
6Azacitidine for the treatment of lower risk myetodysplastic syndromes : a retrospective study of 74 patients enrolled in an Italian named patient program显示文摘Musto P Maurillo L Spagnoli A 2010Cancer2010,116,6:1
7^90Y-ibritumomab tiuxetan as con- solidation therapy after autologous stem cell transplantation in ag- gressive non-Hodgkin lymphoma显示文摘Ria R Musto P Reale A 2011J Nuel Med2011,52,6:1
8Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma显示文摘PALUMBO A BERTOLA A MUSTO P 2005Cancer2005,104,7:1
9Efficacy and safety of bortezomib in patients with plasma cell leukemia 显示文摘Musto P Rossini F Gay F 2007Cancer2007,109,:1
10Effieacy and safety of bortezomib in Patients with Plasma cell leukemia 显示文摘Musto P Rossini F Gay F 2007Cancer2007,109,11:1
11Combined therapy with ami- fostine plus erythropoietin for the treatment of myelodysplastic syn- dromed 显示文摘Grossi A Musto P Santini V 2002Haematologica2002,87,3:1
12Efficacy and safety of bortezomib in patients with plasma cell leukemia显示文摘Musto P Rossini F Gay F 2007Cancer2007,109,11:1
13Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features显示文摘 Musto P Cascavilla N 1998Haematologica1998,83,:1
14Efficacy and safety of bortezomib in patients with plasma cell leukemia显示文摘Musto P Rossini F Gay F 2007Cancer2007,109,11:1
15A prospective randomized trial of oral melphalan,prednisone,thalidomide (MPT) vs oral melphalan,prednisone(MP):an interim analysis显示文摘Palumbo A Bertola A Musto P 2004Blood2004,104,:1
16Final results of a Phase I1 study evaluating lenalidomide in combination with low - dose dexa- methasone as first-line therapy for primary plasma cell leukemia 显示文摘Musto P D'Auria F Petrucci MT 2011Blood ( ASH Annual Meeting Abstracts)2011,118,:1
17Polyimide-silica Hybrids:Spectroscopy, Morphology and Mechanical PropertiesInvestigations显示文摘Musto P Ragosta G Scarinzi G 2004Polymer2004,45,5:1
18A multicenter,randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma显示文摘Musto P Petrucci MT Bringhen S 2008Cancer2008,113,:1
19Effect of the chemical structure of aromatic polyimides on their thermal aging, relaxation behavior and mechanical properties显示文摘RAGOSTA G ABBATE M MUSTO P 2012Journal of Materials Science2012,49,6:1
20Azacitidine for the treatment of lower risk myelodysplastic syndromes:a retrospective study of 74 patients enrolled in an Italian named patient program显示文摘Musto P Maurillo L Spagnoli A 0,,06:1
返回顶部 每页显示:
共8页 首页 上一页 第1页 下一页 末页 /8 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费